期刊文献+

输血量对患者住院时间及费用和结局的影响 被引量:3

Blood transfusion affects the lengths of stay,costs and outcomes of hospital patients
下载PDF
导出
摘要 目的分析输血量对患者住院时间、费用及出院前结局的影响,为推行患者血液管理奠定基础。方法收集本院2016年住院期间进行输血治疗患者数据资料,回顾性分析输血量对住院时间、住院费用及出院前结局的影响。结果不同输血量患者之间的住院总天数、住院费用及扣除术前待床日住院天数(住院天数)差异有统计学意义(P<0.01),总输血量与住院总天数、住院费用、住院天数存在正相关,相关系数分别为0.317、0.497、0.290(P<0.01);与红细胞制剂输注量相比,血浆类制剂输注量与住院总天数、住院费用、住院天数的相关性更强(P<0.05);死亡病例的输血总量显著高于好转出院病例输血总量(P<0.01),其血浆和冷沉淀的输注量也显著高于好转出院病例(P<0.01)。结论输血对住院时间、住院费用及患者结局有影响,血浆类制剂的输注影响更大。 Objective To investigate whether the amount of blood transfusion affects the lengths of stay ( LOS), costs, and outcomes of hospital patients or not, and to prepare for the execution of patient blood management. Methods The data of hospital patients, who had been administrated with blood in our hospital during 2016, were collected. And the influence of blood transfusion volume on LOS, costs and outcomes of patients was analyzed retrospectively. Results LOS, costs and outcomes of patients vary significantly with the amount of blood transfusion (P〈0. 01 ). There were positive correlations between the total amount of blood transfusion and LOS, costs, and outcomes of patients. TheSpearman correlation coefficient was 0. 317, 0. 497, 0. 290, respectively (P〈0. 01). Plasma preparation transfusion volume has a great influence on LOS, costs, and outcomes than red blood cell (P〈0. 05 ). The transfusion volume of death patients was significantly higher than that of the survival (P〈0. 01). In particular, the amount of transfused plasma and precipitation was distinctly higher than that in death patients(P〈0. 01 ). Conclusion Blood transfusion volume affects LOS, costs and outcomes of hospital patients. The administration of plasma preparations should deserve more attention.
出处 《中国输血杂志》 北大核心 2017年第7期727-729,共3页 Chinese Journal of Blood Transfusion
关键词 住院时间 费用 结局 输血 患者血液管理 lengths of stay costs outcomes blood transfusion patient blood management
  • 相关文献

参考文献4

二级参考文献22

  • 1中华人民共和国卫生部.临床输血技术规范[S].卫医发.[2000]184.
  • 2WHO. Blood salty and clinical technology strategy, 2000-- 2003 [M]. Geneva : WHO, 2001 : 2-3.
  • 3World Health Organization. Blood transfusion safety. The clinical use of blood-handbook [C]. Geneva: WHO, 2002.
  • 4American Society of Anesthesiologists. Practice guide lines for perioperative blood transfusion and adjuvant therapies[J].Anesthesiology, 2006, 105(1) : 198-208.
  • 5Schofield WN, Rubin GL, Dean MG. Appropriateness of platelet, fresh frozen plasma and cryprecipitate transfusion in New SouthWales public hospital [J].Medi J Am, 2003, 178(3): 117-120.
  • 6Vamvakas EC. Reasons for moving toward a patient-centric paradigm of clinical transfusion medicine practice[ J]. Transfusion ,2013,53:888-901.
  • 7Accreditation Council for Graduate Medical Education. ACGME program requirements for graduate medical education in blood banking/ transfusion medicine [ S ]. Accreditation Council of Graduate Medical Education, 2009 [ cited 2010 Jun 2 ]. Available from URL: http ://www. acgme, org/acWebsite/downloads/RRC_ progReq/305 pr704, pdf.
  • 8The Joint Commission and the American Medical Association- Convened Physician Consortium for Performance Improvement (PCPI). Proceedings from the National Summit on Overuse [R]. Physician Consortium for Performance Improvement, 2012. Available from URL: http://www, ama-assn, org/rcsources/doc/.
  • 9Shi L, Wang JX, Stevens L, et al. Blood safety and availability : continuing challenges in China' s blood banking system [ J ]. Transfusion,2013, [ Epub ahead of print].
  • 10Spahn DR, Goodnough LT. Ahernatives to blood transfusion [ J ]. Lancet ,2013,381 : 1855-1865.

共引文献28

同被引文献39

引证文献3

二级引证文献10

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部